Aquarius Surgical Technologies Inc. (CSE:ASTI)
Canada · Delayed Price · Currency is CAD 0.0200
0.00 (0.00%)
Aug 21, 2026, 2:10 PM EST
CSE:ASTI Income Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 0.09 | 0.09 | 0.21 | 0.2 | 0.33 |
| 0.09 | 0.09 | 0.21 | 0.2 | 0.33 | |
Revenue Growth | 0.26% | -55.56% | 0.74% | -37.82% | -43.84% |
Cost of Revenue | 0.04 | 0.04 | 0.07 | 0.12 | 0.2 |
Gross Profit | 0.05 | 0.05 | 0.13 | 0.08 | 0.13 |
Selling, General & Admin | 0.29 | 0.56 | 0.59 | 0.73 | 0.77 |
Amortization of Goodwill & Intangibles | 0.02 | 0.03 | 0.03 | 0.01 | 0.05 |
Operating Expenses | 0.31 | 0.59 | 0.62 | 0.73 | 0.82 |
Operating Income | -0.26 | -0.55 | -0.49 | -0.65 | -0.69 |
Interest Expense | -0.4 | -0.3 | -0.29 | -0.2 | -0.2 |
Interest & Investment Income | 0 | 0 | 0 | 0.01 | 0.01 |
Other Non Operating Income (Expenses) | -0.01 | -0.01 | 0.03 | -0.02 | -0.02 |
EBT Excluding Unusual Items | -0.66 | -0.86 | -0.75 | -0.86 | -0.89 |
Gain (Loss) on Sale of Investments | - | -0.3 | 0 | 0.02 | 0.28 |
Asset Writedown | - | - | - | - | -0.25 |
Other Unusual Items | 0.02 | - | - | 0.12 | - |
Pretax Income | -0.65 | -1.17 | -0.75 | -0.72 | -0.86 |
Income Tax Expense | 0.01 | 0 | 0.01 | - | - |
Net Income | -0.65 | -1.17 | -0.76 | -0.72 | -0.86 |
Net Income to Common | -0.65 | -1.17 | -0.76 | -0.72 | -0.86 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 28 | 28 | 28 | 25 | 24 |
Shares Outstanding (Diluted) | 28 | 28 | 28 | 25 | 24 |
Shares Change | - | - | 11.06% | 4.94% | 3.24% |
EPS (Basic) | -0.02 | -0.04 | -0.03 | -0.03 | -0.04 |
EPS (Diluted) | -0.02 | -0.04 | -0.03 | -0.03 | -0.04 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -0.12 | -0.38 | -0.26 | 0.04 | -0.12 |
Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | 0.00 | -0.01 |
Gross Margin | 53.67% | 51.87% | 64.73% | 40.21% | 39.77% |
Operating Margin | -281.59% | -598.19% | -238.54% | -319.89% | -209.79% |
Profit Margin | -712.75% | -1279.85% | -369.14% | -355.09% | -262.22% |
Free Cash Flow Margin | -127.26% | -420.26% | -125.18% | 19.06% | -35.82% |
EBITDA | -0.25 | -0.54 | -0.49 | -0.65 | -0.64 |
EBITDA Margin | -271.84% | - | -236.53% | - | -194.20% |
D&A For EBITDA | 0.01 | 0 | 0 | 0 | 0.05 |
EBIT | -0.26 | -0.55 | -0.49 | -0.65 | -0.69 |
EBIT Margin | -281.59% | - | -238.54% | - | -209.79% |
Revenue as Reported | 0.09 | 0.09 | 0.21 | 0.2 | 0.33 |